Literature DB >> 3528776

Ginger: inhibition of thromboxane synthetase and stimulation of prostacyclin: relevance for medicine and psychiatry.

J Backon.   

Abstract

Ginger, the common spice, has recently been found to act as a potent inhibitor of thromboxane synthetase, raising levels of prostacyclin, without a concomitant rise in PGE2 or PGF2 alpha. Indications for use of ginger to replace either thromboxane inhibitors having serious side effects or prostacyclin are given.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3528776     DOI: 10.1016/0306-9877(86)90043-5

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

1.  Taking ginger for nausea and vomiting during pregnancy.

Authors:  Kiran Chandra; Adrienne Einarson; Gideon Koren
Journal:  Can Fam Physician       Date:  2002-09       Impact factor: 3.275

2.  Ginger and carbon dioxide as thromboxane synthetase inhibitors: potential utility in treating peptic ulceration.

Authors:  J A Backon
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

Review 3.  Anti-coagulant activity of plants: mini review.

Authors:  Muhammad Akram; Abid Rashid
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

Review 4.  Plants against Helicobacter pylori to combat resistance: An ethnopharmacological review.

Authors:  Doha Abou Baker
Journal:  Biotechnol Rep (Amst)       Date:  2020-05-21

5.  Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health Transition.

Authors:  Nicholas E Thomford; Kevin Dzobo; Denis Chopera; Ambroise Wonkam; Michelle Skelton; Dee Blackhurst; Shadreck Chirikure; Collet Dandara
Journal:  Pharmaceuticals (Basel)       Date:  2015-09-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.